Analysts Set Expectations for TRDA Q4 Earnings
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) – Research analysts at Roth Capital issued their Q4 2026 earnings estimates for shares of Entrada Therapeutics in a research note issued to investors on Friday, February 28th. Roth Capital analyst B. Pachaiyappan expects that the company will earn ($0.86) per share for the quarter. Roth Capital has […]
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) – Research analysts at Roth Capital issued their Q4 2026 earnings estimates for shares of Entrada Therapeutics in a research note issued to investors on Friday, February 28th. Roth Capital analyst B. Pachaiyappan expects that the company will earn ($0.86) per share for the quarter. Roth Capital has […]
